KAYLEIGH BABB: Open Payments
NPI 1982206694 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 4 payments from 4 companies in 2025. Trend: 2023 $150 · 2024 $169 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $124 |
| ABBVIE INC. | 1 | $103 |
| Regeneron Healthcare Solutions, Inc. | 1 | $92 |
| Lilly USA, LLC | 1 | $18 |
Products named: DALVANCE, DUPIXENT, MOUNJARO.
Industry payments across IN — which companies pay providers there.
